FAULKNER HOSPITAL — History
CCN 220119 | 3-year financial timeline | COVID resilience: 55/100
🛡️ Public data only — no PHI permitted on this instance.
$317M
Latest Revenue (FY2022)
+6.8%
Revenue CAGR (3yr)
-7.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $278M | $318M | $317M | -0.3% | +6.8% |
| Operating Expenses | $292M | $316M | $342M | +8.1% | +8.1% |
| Operating Margin | -5.3% | 0.5% | -7.9% | -1828.5% | +0.0% |
| Net Income | $-15M | $1M | $-25M | -1823.4% | +0.0% |
| Licensed Beds | 147 | 147 | 147 | +0.0% | +0.0% |
| Total Patient Days | 35,895 | 38,581 | 38,594 | +0.0% | +3.7% |
| Medicare Day % | 46% | 47% | 47% | -0.4% | +1.3% |
| Medicaid Day % | 5% | 5% | 4% | -14.7% | -5.3% |
COVID Impact & Recovery
Resilience Score: 55/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.1% ($278M → $317M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+6.8%
This Hospital
+7.6%
State Avg
Latest Margin
-7.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $336M | -9.2% |
| FY2024 (proj) | $356M | -10.5% |
| FY2025 (proj) | $375M | -11.8% |